ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)

Market Cap	6.06B
Revenue (ttm)	536.35M
Net Income (ttm)	80.67M
Shares Out	157.39M
EPS (ttm)	0.50
PE Ratio	76.33
Forward PE	39.33
Dividend	0.10 (0.26%)
Ex-Dividend Date	Jun 13, 2025

Volume	6,440,375
Average Volume	9,954,452
Open	38.09
Previous Close	38.18
Day's Range	37.06 - 38.99
52-Week Range	15.72 - 44.19
Beta	0.92
RSI	50.93
Earnings Date	Aug 15, 2025

About Acelyrin

ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company produces polypeptide APIs, tablets of solid preparation, bottles of freeze-dried powder injections, small-volume injections, pre-filled injections, and card type injections. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,381
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688117

Financial Performance

In 2024, ChengDu ShengNuo Biotec's revenue was 456.07 million, an increase of 4.84% compared to the previous year's 435.02 million. Earnings were 50.02 million, a decrease of -28.88%.